Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contribution of CB2 receptors in schizophrenia-related symptoms in various animal models: Short review
Izabela Banaszkiewicz, Grażyna Biała, Marta Kruk-Słomka
Neuroscience & Biobehavioral Reviews (2020) Vol. 114, pp. 158-171
Closed Access | Times Cited: 17

Showing 17 citing articles:

Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system
Danko Jeremic, Irene Sánchez‐Rodríguez, Lydia Jiménez‐Díaz, et al.
Pharmacology & Therapeutics (2021) Vol. 223, pp. 107808-107808
Open Access | Times Cited: 65
Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia
Gerwyn Morris, Luba Sominsky, Kenneth R. Walder, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3485-3503
Closed Access | Times Cited: 30
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Daniela Navarro, Ani Gasparyan, Francisco Navarrete, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4764-4764
Open Access | Times Cited: 26
The 3-hit animal models of schizophrenia: Improving strategy to decipher and treat the disease?
Solenn Percelay, Caroline Lahogue, Jean‐Marie Billard, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 157, pp. 105526-105526
Closed Access | Times Cited: 4
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1
Marc Ten-Blanco, África Flores, Inmaculada Pereda-Pérez, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112925-112925
Open Access | Times Cited: 18
Mood, Motivation, and Mental Health
Jean-Paul Henri Dedam, Matthew Fogel, Elizabeth Fogel
(2025), pp. 109-122
Closed Access
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Isadora Lopes Cortez, Naielly Rodrigues da Silva, Francisco Silveira Guimarães, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 24
The CB2 cannabinoid receptor as a therapeutic target in the central nervous system
David Cabañero, Elena Martín‐García, Rafaël Maldonado
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 8, pp. 659-676
Closed Access | Times Cited: 16
Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder
Ana Canseco-Alba, Branden Sanabria, Mariam Hammouda, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 10
Effects of endocannabinoid system modulation on social behaviour: A systematic review of animal studies
Mashal Ahmed, Laura M. Best, Christina F. Pereira, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 138, pp. 104680-104680
Closed Access | Times Cited: 8
El gen del receptor cannabinoide tipo 2 se asocia con la comorbilidad entre esquizofrenia y dependencia de cannabis y el gen de la enzima amidohidrolasa de ácidos grasos se asocia con la dependencia de cannabis en población española
F. Árias, José Ramón Dávila Píriz, Alba Parra González, et al.
Adicciones (2021) Vol. 35, Iss. 1, pp. 33-33
Open Access | Times Cited: 10
Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication
Natalia Mansur Haddad, Leonardo Peroni De Jesus, Maurício H. Serpa, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 1
CB2 cannabinoid receptor expression is increased in 129S1/SvImJ mice: behavioral consequences
Marc Ten-Blanco, Inmaculada Pereda-Pérez, Cristina Izquierdo-Luengo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Clinical and cognitive outcomes in first-episode psychosis: focus on the interplay between cannabis use and genetic variability in endocannabinoid receptors
Maitane Oscoz-Irurozqui, Maria Guardiola-Ripoll, Carmen Almodóvar-Payá, et al.
Frontiers in Psychology (2024) Vol. 15
Open Access
Anti-aversive effect of 2-arachidonoylglycerol in the dorsolateral periaqueductal gray of male rats in contextual fear conditioning and Vogel tests
Rayssa C. Briânis, Rita Lima, Fabrício A. Moreira, et al.
Behavioural Pharmacology (2021) Vol. 33, Iss. 2&3, pp. 213-221
Closed Access | Times Cited: 2
Differential sphingosine-1-phosphate receptor-1 protein expression in the dorsolateral prefrontal cortex between schizophrenia Type 1 and Type 2
Ganesh B. Chand, Hao Jiang, J. Philip Miller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Efeito de antipsicóticos e canabidiol em cultura de oligodendrócitos tratados com cuprizona
Ana Caroline Brambilla Falvella
(2020)
Open Access
Page 1

Scroll to top